Sponsored by:

Molecular Imaging: Page 443

FDA clears software for liver, gallbladder diagnosis
By AuntMinnie.com staff writers
A software package designed to assist with the clinical diagnosis of liver and gallbladder diseases has been cleared by the U.S. Food and Drug Administration (FDA).
March 11, 2008
EUSA Pharma to acquire Cytogen
By AuntMinnie.com staff writers
Specialty pharmaceutical company EUSA Pharma of Oxford, U.K., has entered into a definitive agreement to acquire biopharmaceutical firm Cytogen for $22.6 million.
March 10, 2008
PET/CT beats 3T MRI in whole-body primary tumor staging
By Rob Skelding
VIENNA - Finding how far a patient's cancer has spread is critical in planning and optimizing treatment. Various imaging techniques now provide indispensable tools for staging primary tumors, but a new comparative study found fused whole-body PET/CT to be significantly more accurate than whole-body MRI -- even at 3 tesla -- for primary tumor staging.
March 9, 2008
UC-Davis develops PET/MRI scanner
By AuntMinnie.com staff writers
The biomedical engineering department at the University of California, Davis, has developed a PET/MRI scanner. The system is designed to study laboratory mice for cancer research, according to Simon Cherry, professor and chair of biomedical engineering.
March 6, 2008
IBA posts mixed results for 2007
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve posted strong revenue increases but also a decline in profit in 2007.
March 6, 2008
Reactor shutdown hurts MDS Nordion's Q1
By AuntMinnie.com staff writers
The shutdown last year of the Chalk River nuclear reactor in Canada affected the first-quarter financial results of radioisotope developer MDS Nordion.
March 5, 2008
FDG-PET/CT aids in radiation therapy planning
By Wayne Forrest
For head and neck carcinoma, using FDG-PET/CT leads to more accurate staging, appropriate changes in radiation therapy planning, and potentially superior patient outcomes, according to a new study by researchers from Wisconsin.
March 4, 2008
Biotage, McMaster extend molecular imaging deal
By AuntMinnie.com staff writers
Swedish life sciences firm Biotage and McMaster University of Hamilton, Ontario, have inked a two-year extension to their molecular imaging development pact.
March 3, 2008
AMIC to begin isotope production
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope (AMIC) has installed a compact linear accelerator to provide isotope production capabilities in North America.
March 3, 2008
NuView inks deal with USC
By AuntMinnie.com staff writers
Radiopharmaceutical developer NuView Radiopharmaceuticals has signed an exclusive license agreement with the University of Southern California (USC) in Los Angeles.
March 2, 2008
IsoRay chief executive steps down
By AuntMinnie.com staff writers
The chief executive of medical isotope developer IsoRay of Richland, WA, has left the company.
February 26, 2008
Covidien gets tentative nod for generic sestamibi
By AuntMinnie.com staff writers
Covidien has received tentative approval from the U.S. Food and Drug Administration (FDA) for a generic version of the Cardiolite technetium sestamibi radiopharmaceutical for myocardial perfusion studies.
February 26, 2008
Previous Page
Page 443 of 615
Next Page